GATA2 and posterior cortical atrophy: The results showed that GATA2 expression levels are higher in patient group with GATA2 copy number gain in two independent clinical PCa datasets (Fig. 1c, d and Fig. S1d), consistent with previous notion that the genes with copy number amplification in cancer genome often show increased expression levels leading to altered activity in tumor cell growth and progression [11, 12].